HOME >> MEDICINE >> NEWS
Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO

The Institute for Global Tobacco Control (IGTC) at the Johns Hopkins Bloomberg School of Public Health has been designated a "collaborating center" of the Pan American Health Organization (PAHO) and World Health Organization (WHO). As a collaborating center, the IGTC will work to support global efforts to reduce tobacco use. The IGTC is one of three tobacco control surveillance and evaluation collaborating centers in the United States, joining the federal Centers for Disease Control and Prevention and the University of California, San Francisco Center for Tobacco Control Research and Education.

The IGTC will promote research, surveillance, evaluation and training in support of a progressive and aggressive policy development agenda. These activities play a critical role in building and maintaining strong tobacco control programs. The IGTC has been active in all of these areas throughout the world. It participated in the 1996 national smoking survey in China and recently conducted an assessment of second-hand smoke exposure across Latin America.

"The IGTC was selected to be a collaborating center as a result of its commitment to combating the global tobacco epidemic. As part of the School and the Department of Epidemiology, we have an extensive network of partnerships and collaborations that have been established by our faculty. The Institute is in a position to offer real and lasting approaches to control and prevent tobacco-related death and disease," said Jonathan Samet, director of the IGTC and chair and professor in the Bloomberg School of Public Health's Department of Epidemiology.

Dr. Samet, an international authority on tobacco's effects on health, explained that the research of the Institute is imperative. "Knowing the scale of a country's tobacco epidemic, as well as the machinations of tobacco companies, can give researchers the evidence needed to convince governments to adopt new policies and intervention programs," he said. '"/>

Contact: Kenna L. Lowe
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
19-Nov-2004


Page: 1 2

Related medicine news :

1. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
2. Earlier use of prostate cancer vaccines urged by Hopkins scientists
3. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
4. Johns Hopkins scientists receive presidential medals
5. Hunt for autism genes to be led by Hopkins researchers
6. Most household cleaners remove peanut allergens, Hopkins study shows
7. Exercise Hypertension occurs when cells cant relax, Hopkins researchers find
8. Hopkins young researchers honored for their contributions
9. Hopkins researchers find MRI useful tool in diagnosing inflammatory bowel diseases in children
10. Hopkins Peter Agre receives 2003 Nobel Prize in chemistry
11. Hopkins researchers study heart defect that kills athletes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
Cached News: